Form 4: Generation Bio CFO Reports Routine Stock Transactions and RSU Vesting

Generation Bio Co.'s Chief Financial Officer, Kevin John Conway, reported the acquisition of common stock through restricted stock unit vesting and subsequent disposition of shares for tax purposes on July 15, 2025.

Summary

• Kevin John Conway, Chief Financial Officer of Generation Bio Co. (GBIO), reported transactions involving the company's common stock and restricted stock units (RSUs).
• On July 15, 2025, Conway acquired 587 shares of common stock through the vesting and conversion of restricted stock units.
• Concurrently, 173 shares of common stock were disposed of at a price of $0.426 per share, likely to cover tax liabilities associated with the RSU vesting.
• Following these transactions, Conway directly holds 18,273 shares of common stock.
• The original grant of 9,390 restricted stock units occurred on January 20, 2023, with 25% vesting on January 15, 2024, and the remainder vesting in equal quarterly installments thereafter.
• After the conversion of 587 RSUs, Conway directly holds 3,520 unvested restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's a disposition of shares, it's for tax purposes related to RSU vesting, which is a standard compensation event. The acquisition of shares through vesting increases the insider's direct ownership from the RSU pool, aligning interests.

Positives

• The vesting of restricted stock units indicates the fulfillment of compensation agreements, potentially aligning management's interests with shareholders through equity ownership.

Negatives

• The disposition of 173 shares, even if for tax purposes, results in a slight reduction in the direct common stock holdings of the Chief Financial Officer.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The report provides transparency on insider holdings and compensation, which can influence investor confidence. The disposition of shares for tax purposes is a common practice and generally not seen as a negative signal regarding company prospects.

Next Steps

• Remaining restricted stock units will continue to vest in equal quarterly installments after January 15, 2024.

Key Dates

Keywords

SEC Form 4, insider transaction, Generation Bio Co., GBIO, restricted stock units, RSU vesting, common stock, Chief Financial Officer, Kevin John Conway, stock disposition, tax withholding